Venlafaxine formulations
US6703044B1 · kind B1 · utility
19Cited by
10References
63Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2002 |
| Grant date | Mar 9, 2004 |
| Priority date | — |
| Expiry date | Oct 25, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2886
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method for treating a subject with venlafaxine, comprising administering to the subject a formulation having a therapeutically effective amount of venlafaxine or a pharmaceutically acceptable salt thereof, wherein the formulation provides a delayed burst release after at least three hours resulting in dispersion mainly through the colon of the active ingredient into the blood stream as a result of colon absorption over a period of at least 24 hours.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.